244 related articles for article (PubMed ID: 34926571)
21. SERPINH1 is a Potential Prognostic Biomarker and Correlated With Immune Infiltration: A Pan-Cancer Analysis.
Wang Y; Gu W; Wen W; Zhang X
Front Genet; 2021; 12():756094. PubMed ID: 35058967
[No Abstract] [Full Text] [Related]
22. A Pan-Cancer Analysis Reveals the Prognostic and Immunotherapeutic Value of Stanniocalcin-2 (STC2).
Jiang ZH; Shen X; Wei Y; Chen Y; Chai H; Xia L; Leng W
Front Genet; 2022; 13():927046. PubMed ID: 35937984
[No Abstract] [Full Text] [Related]
23. The Antitumor Effect of Caffeic Acid Phenethyl Ester by Downregulating Mucosa-Associated Lymphoid Tissue 1 via AR/p53/NF-κB Signaling in Prostate Carcinoma Cells.
Chang KS; Tsui KH; Hsu SY; Sung HC; Lin YH; Hou CP; Yang PS; Chen CL; Feng TH; Juang HH
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053438
[TBL] [Abstract][Full Text] [Related]
24. Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice.
Vicente-Dueñas C; Fontán L; Gonzalez-Herrero I; Romero-Camarero I; Segura V; Aznar MA; Alonso-Escudero E; Campos-Sanchez E; Ruiz-Roca L; Barajas-Diego M; Sagardoy A; Martinez-Ferrandis JI; Abollo-Jimenez F; Bertolo C; Peñuelas I; Garcia-Criado FJ; García-Cenador MB; Tousseyn T; Agirre X; Prosper F; Garcia-Bragado F; McPhail ED; Lossos IS; Du MQ; Flores T; Hernandez-Rivas JM; Gonzalez M; Salar A; Bellosillo B; Conde E; Siebert R; Sagaert X; Cobaleda C; Sanchez-Garcia I; Martinez-Climent JA
Proc Natl Acad Sci U S A; 2012 Jun; 109(26):10534-9. PubMed ID: 22689981
[TBL] [Abstract][Full Text] [Related]
25. A systemic pan-cancer analysis of MPZL3 as a potential prognostic biomarker and its correlation with immune infiltration and drug sensitivity in breast cancer.
Huang R; Li L; Wang Z; Shen K
Front Oncol; 2022; 12():901728. PubMed ID: 35965540
[TBL] [Abstract][Full Text] [Related]
26. Systematic Investigation of the Multifaceted Role of
Sun Q; Du J; Dong J; Pan S; Jin H; Han X; Zhang J
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551589
[TBL] [Abstract][Full Text] [Related]
27. FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration.
Cai J; Ye Z; Hu Y; Wang Y; Ye L; Gao L; Sun Q; Tong S; Sun Z; Yang J; Chen Q
Front Oncol; 2022; 12():998336. PubMed ID: 36185230
[TBL] [Abstract][Full Text] [Related]
28. Prognostic Implication and Oncogenic Role of PNPO in Pan-Cancer.
Zhang L; Li X; Zhang J; Xu G
Front Cell Dev Biol; 2021; 9():763674. PubMed ID: 35127701
[No Abstract] [Full Text] [Related]
29. MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells.
Ho L; Davis RE; Conne B; Chappuis R; Berczy M; Mhawech P; Staudt LM; Schwaller J
Blood; 2005 Apr; 105(7):2891-9. PubMed ID: 15598810
[TBL] [Abstract][Full Text] [Related]
30. Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis.
Yang L; Zhang Y; Wang Y; Jiang P; Liu F; Feng N
Front Pharmacol; 2022; 13():938134. PubMed ID: 36210836
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer.
Zhu HZ; Zhou WJ; Wan YF; Ge K; Lu J; Jia CK
World J Gastroenterol; 2020 Feb; 26(8):804-817. PubMed ID: 32148378
[TBL] [Abstract][Full Text] [Related]
32. Pan-Cancer Analysis of FURIN as a Potential Prognostic and Immunological Biomarker.
Zhou B; Gao S
Front Mol Biosci; 2021; 8():648402. PubMed ID: 33968987
[TBL] [Abstract][Full Text] [Related]
33. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
[TBL] [Abstract][Full Text] [Related]
34. [Detection of API2-MALT1 fusion gene in extranodal B-cell lymphoma and its significance].
Yang WX; Li GD; Zhou Q; Liu WP; Li L; Chen N
Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):92-6. PubMed ID: 16630483
[TBL] [Abstract][Full Text] [Related]
35. The prognostic and immunological effects of ZBTB7C across cancers: friend or foe?
Chen X; Jiang Z; Wang Z; Jiang Z
Aging (Albany NY); 2021 May; 13(9):12849-12864. PubMed ID: 33946045
[TBL] [Abstract][Full Text] [Related]
36. Z-VRPR-FMK can inhibit the growth and invasiveness of diffuse large B-cell lymphoma by depressing NF-κB activation and MMP expression induced by MALT1.
Feng J; Yang W; Wang J; Pu Z; Han Y; Wan L
Int J Clin Exp Pathol; 2019; 12(6):1947-1955. PubMed ID: 31934017
[TBL] [Abstract][Full Text] [Related]
37. Systematic Analysis of Coronavirus Disease 2019 (COVID-19) Receptor ACE2 in Malignant Tumors: Pan-Cancer Analysis.
Song J; Han J; Liu F; Chen X; Qian S; Wang Y; Jia Z; Duan X; Zhang X; Zhu J
Front Mol Biosci; 2020; 7():569414. PubMed ID: 33195415
[TBL] [Abstract][Full Text] [Related]
38. Multi-omics analysis of LAMB3 as a potential immunological and biomarker in pan-cancer.
Wang Y; Li G; Wang Z; Wang W; Wang X; Luo X; Zhao J; Li F; Bian L
Front Mol Biosci; 2023; 10():1157970. PubMed ID: 37577750
[TBL] [Abstract][Full Text] [Related]
39. Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma.
Hailfinger S; Lenz G; Ngo V; Posvitz-Fejfar A; Rebeaud F; Guzzardi M; Penas EM; Dierlamm J; Chan WC; Staudt LM; Thome M
Proc Natl Acad Sci U S A; 2009 Nov; 106(47):19946-51. PubMed ID: 19897720
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of CARMA1-BCL10-MALT1-A20-NF-κB expression in T cell-acute lymphocytic leukemia.
Ma Y; Liao Z; Xu Y; Zhong Z; Wang X; Zhang F; Chen S; Yang L; Luo G; Huang X; Huang S; Wu X; Li Y
Eur J Med Res; 2014 Nov; 19(1):62. PubMed ID: 25384343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
